A detailed history of Range Financial Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Range Financial Group LLC holds 14,162 shares of ABBV stock, worth $2.43 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
14,162
Previous 13,908 1.83%
Holding current value
$2.43 Million
Previous $2.16 Million 19.63%
% of portfolio
1.35%
Previous 1.32%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$159.82 - $182.1 $40,594 - $46,253
254 Added 1.83%
14,162 $2.58 Million
Q4 2023

Jan 10, 2024

SELL
$137.6 - $154.97 $221,398 - $249,346
-1,609 Reduced 10.37%
13,908 $2.16 Million
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $44,752 - $51,807
-335 Reduced 2.11%
15,517 $2.31 Million
Q2 2023

Jul 18, 2023

SELL
$132.51 - $164.9 $1.31 Million - $1.63 Million
-9,863 Reduced 38.36%
15,852 $2.14 Million
Q1 2023

Apr 03, 2023

SELL
$144.61 - $166.54 $71,871 - $82,770
-497 Reduced 1.9%
25,715 $4.1 Million
Q4 2022

Jan 13, 2023

BUY
$138.31 - $165.87 $83,539 - $100,185
604 Added 2.36%
26,212 $0
Q3 2022

Oct 13, 2022

SELL
$134.21 - $153.93 $451,482 - $517,820
-3,364 Reduced 11.61%
25,608 $3.44 Million
Q2 2022

Jul 11, 2022

SELL
$137.62 - $174.96 $122,206 - $155,364
-888 Reduced 2.97%
28,972 $4.44 Million
Q1 2022

May 18, 2022

SELL
$131.98 - $163.75 $32,467 - $40,282
-246 Reduced 0.82%
29,860 $4.84 Million
Q4 2021

Jul 11, 2022

BUY
$107.43 - $135.93 $38,674 - $48,934
360 Added 1.21%
30,106 $4.08 Million
Q3 2021

Jul 11, 2022

BUY
$106.4 - $120.78 $53,944 - $61,235
507 Added 1.73%
29,746 $3.21 Million
Q2 2021

Jul 11, 2022

BUY
$105.21 - $117.21 $203,265 - $226,449
1,932 Added 7.08%
29,239 $3.29 Million
Q1 2021

Jul 11, 2022

BUY
$102.3 - $112.62 $2.79 Million - $3.08 Million
27,307 New
27,307 $2.96 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Range Financial Group LLC Portfolio

Follow Range Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Range Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Range Financial Group LLC with notifications on news.